News Website

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study - BMC Medicine

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study BMC Medicine

Published: Dec. 18, 2024, 8:05 p.m.

Read Full Article

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN

Published: Dec. 17, 2024, 1:27 p.m.

Read Full Article

Comment: Dervilia Kernaghan: 'Reforming women’s healthcare requires more than reports and acknowledgements; it demands immediate and meaningful action. Women deserve better, and it is high time we delivered on that promise' - http://www.viewdigital.org

Comment: Dervilia Kernaghan: 'Reforming women’s healthcare requires more than reports and acknowledgements; it demands immediate and meaningful action. Women deserve better, and it is high time we delivered on that …

Published: Dec. 17, 2024, 8:39 a.m.

Read Full Article

Queensland public servants to get paid leave for reproductive healthcare - MSN

Queensland public servants to get paid leave for reproductive healthcare MSN

Published: Dec. 14, 2024, 7:51 a.m.

Read Full Article

Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks - Frontiers

Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks Frontiers

Published: Dec. 14, 2024, 1:31 a.m.

Read Full Article

Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Repare Therapeutics eyes Phase III cancer study after Mythic trial success Yahoo Finance

Published: Dec. 13, 2024, 3:28 p.m.

Read Full Article

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial CRISPR Medicine News

Published: Dec. 13, 2024, 12:56 p.m.

Read Full Article

‘Medical Misogyny’ leaves women in years of gynaecological pain: reports - Head Topics

‘Medical Misogyny’ leaves women in years of gynaecological pain: reports Head Topics

Published: Dec. 13, 2024, 11:18 a.m.

Read Full Article

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial BioSpace

Published: Dec. 12, 2024, 11:25 p.m.

Read Full Article

How depression and period pain are connected - MSN

How depression and period pain are connected MSN

Published: Dec. 12, 2024, 9:11 p.m.

Read Full Article

Latest Articles

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study - BMC Medicine

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN

Comment: Dervilia Kernaghan: 'Reforming women’s healthcare requires more than reports and acknowledgements; it demands immediate and meaningful action. Women deserve better, and it is high time we delivered on that promise' - http://www.viewdigital.org

Queensland public servants to get paid leave for reproductive healthcare - MSN

Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks - Frontiers

Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

‘Medical Misogyny’ leaves women in years of gynaecological pain: reports - Head Topics

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

How depression and period pain are connected - MSN

Subscribe to Our Newsletter